Announcements & Media Coverage

Convertible Loans Repayment - 14:39 24/24/2021
Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”)   Convertible Loans Repayment   As originally announced in October 2018, Hemogenyx-Cell S.A. (“Hemogenyx-Cell”) and Immugenyx LLC (“Immugenyx”), each wholly-owned subsidiaries of Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, each entered into separate convertible loan notes (the “Notes”)...